Ticker Details
Vera Therapeutics, Inc.
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.90 | 3.72%
Avg Daily Range (30 D):	$1.13 | 3.26%
Avg Daily Range (90 D):	$1.01 | 2.80%

Institutional Daily Volume
Avg Daily Volume:	.64M
Avg Daily Volume (30 D):	1.6M
Avg Daily Volume (90 D):	1.38M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	2,535
Avg Institutional Trade:	$2.53M
Avg Institutional Trade (30 D):	$3.61M
Avg Institutional Trade (90 D):	$3.44M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.17M
Avg Closing Trade (30 D):	$6.86M
Avg Closing Trade (90 D):	$6.63M
Avg Closing Volume:	129.89K

News

Jul 9, 2026 @ 12:00 PM Vera Therapeutics Announces Appointment of Nancy B... Source: Na

May 26, 2026 @ 6:29 PM Investment Firm Closes Out Entire $18.1 Million Po... Source: Jake Lerch

Apr 29, 2026 @ 5:00 PM IgA Nephropathy Market Forecast to 2036: Novel The... Source: Delveinsight

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Mar 13, 2026 @ 2:36 PM This Fund Bet $200 Million on a Biotech Stock Up 5... Source: Jonathan Ponciano

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-5.86	$-1.52	$-1.69
Diluted EPS	$-5.86	$-1.52	$-1.69
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-401.9M	$-109.47M	$-121.03M
Operating Income / Loss	$-415.76M	$-112.49M	$-125.13M
Cost of Revenue
Net Cash Flow	$-.25M	$-65.48M	$-240.37M
PE Ratio